Top Markets
Coin of the day
Metagenomi, Inc. Common Stock Metagenomi, Inc. Common Stock

Metagenomi, Inc. Common Stock

MGX
Rang în acțiuni #25865
Metagenomi, Inc. operates as a biotechnology company focused on gene editing,... Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.
Preț acțiune
$1.21
Ultima sincronizare: 2026-08-20
Capitalizare de piață
$45.55M
Schimbare (1 zi)
-2.43%
Schimbare (1 an)
-34.60%
Țară
US
Tranzacționează Metagenomi, Inc. Common Stock (MGX)

Categorie

Istoric al prețului acțiunii pentru Metagenomi, Inc. Common Stock (MGX)
Cel mai mare preț de închidere: $1.22 pe 2026-08-01

Cel mai mic preț de închidere: $11.71 pe 2024-02-01
Istoric al prețului acțiunii pentru Metagenomi, Inc. Common Stock din 2024 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -2.20%
2025 -48.40%
2024 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$539.14 35.65%
US
$1.04K 56.21%
NL
$119.69 -17.56%
AU
$761.87 8.65%
CH
$130.43 397.46%
US